Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any minute actually - needs to be filed by midnight EST.
Correct - they keep it secret so there is no chance of any shady behavior by hooligans ( like MRC)
BioB - but what about the new ANDA filers coming up behind the first 2? How does a settlement make those go away?
No large association came to Amarins defense. Two were submitted but nothing that will probably matter.
Another ANDA get approved by another generic that we have not seen yet?
Another fund selling off....running from the June 16th date most likely
MRC go away
Not just a heart breaker but a bank breaker. The amount of money (opportunity cost) that we’ve all lost sitting it here is hard to even calculate when our economy has been booming while stock market has been making crazy moves.
**with small correction for COVID-19 games
I can help with that
“Judge Du is correct. Her judgment should stand. She is smart and Amarin is not”.
There is not much they can say - thus the thought their response will be very weak and will be a stock price catalyst.
WOW - So great to see the great Dr. speak his mind.
Exactly - and because DU based her her decision on it - then should Bhatt new analysts be allowed as a follow up. Everyone seems to say no - because it would be new evidence. That just seems unfair.
You should kindly encourage him
Can they not submit it after the generics upload their response on June 16?
Did you see Dr. Bhatts answer of “is this being sent to appeals court in some fashion?
Response from Dr. Bhatt (copied):
RT @DLBHATTMD: @Docjoshsoc @SSRN The first author did email the manuscript to the Judge (or at least the email that is publicly listed). So, hopefully it gets to her.
Wow - even co authored by Bhatt
I use Fidelity and I’m very satisfied.
I got an email from fidelity this morning. There was a link on the email - it was easy.
VOTED NO TO ALL
Opportunity cost of owning this is High
yes - captain obvious statement.... but soooo frustrating
Solid 6 month chart
I think everyone wants to move on at this point....that’s been here awhile
Yup - I’ve been reducing to jump on other deals until more in known.....too many great deals to miss
Look at the book value alone .......$5.92
Nice find
Ah - did not realize that....thanks for clarification
Probably just doing paperwork ahead of phase 1 finishing
READ
I’m BULLISH NOW - they now know dosage....they will tweak and work with FDA....this price is a gift
64 mg dose was statistically significantly different from placebo as measured by change in PSP at all other assessment timepoints (Week 4, nominal p ≤0.005, ES=0.3; Week 8: nominal p ≤0.018, ES=0.3).
“The substantial improvements in the PSP scale with the 64 mg dose are tremendously encouraging. These study results represent a very important outcome in a study of a potential treatment of negative symptoms, one of the most important drivers of everyday disability and a critical unmet medical need for patients with schizophrenia. The consistency in treatment effects, in terms of overall negative symptoms and of the most important subtype, reduced emotional experience, between the previous Phase 2b study and the current one is encouraging. The increased placebo effect from the first to second study seems to be the only reason that the study did not meet its primary endpoint.”
Why would Mochida Pharmaceutical be running this
Court won’t even know - and wont care honestly
They had a 12 million market cap. We have a 2.5B
BIG difference....room to run more tomm....could run to $50 a share with low float and continued short activity
Slow bleed until when? What’s the floor?
We are 4X rev as a market cap now - what gives
What a crazy day - still should get steam in afternoon - $20 target
Unless a contingent deal has been on the table pending certain milestones .....and those milestones keep getting kicked down the road... i.e. trial loss, US market on hold
They simply could be in a silent period unable to exercise any buys/sells outside of predefined sales or auto sells for taxes on grant issues
Confirmed....interesting
There is already another generic behind them....no settlement chance now that verdict has happened.....the door is open and more and more generics will be coming